Overview

Antibiotics Treatment of Cholangitis Post-Kasai Portoenterostomy

Status:
Not yet recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
Application of multi-center, prospective study on the severity of postoperative cholangitis biliary atresia classification, according to the degree of cholangitis targeted therapy, to improve the therapeutic effect of postoperative cholangitis biliary atresia, decrease the overuse of antibiotics related complications.
Phase:
Phase 4
Details
Lead Sponsor:
Tongji Hospital
Collaborator:
Shanghai Children's Hospital
Treatments:
Meropenem
Sulperazone
Teicoplanin
Tinidazole